COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)
Clinical trial NCT04367402 · UNKNOWN
Trial details
- NCT number
- NCT04367402
- Sponsor
- Azienda Ospedaliera San Paolo
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-30
- Primary completion
- 2020-04-24
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.